TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Veradigm ( (MDRX) ) has shared an announcement.
On July 24, 2025, Veradigm Inc. amended its Stockholder Agreement with Charles and Jessica Myers, extending the termination date to January 26, 2026, and allowing the Myers Parties to trade company securities under certain conditions. Additionally, with the termination of Thomas Langan’s employment on July 31, 2025, Veradigm established an Interim Office of the Chief Executive Officer effective August 1, 2025, comprising Jay Bhattacharyya, Eric Jacobson, and Lee Westerfield, who will serve as the principal executive officers.
The most recent analyst rating on (MDRX) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Veradigm stock, see the MDRX Stock Forecast page.
More about Veradigm
Veradigm Inc. operates in the healthcare technology industry, providing data-driven solutions and services aimed at improving healthcare delivery and outcomes. The company focuses on payer and life sciences sectors, offering analytics and coordination tools.
Average Trading Volume: 167,712
Technical Sentiment Signal: Sell
Current Market Cap: $788.5M
See more insights into MDRX stock on TipRanks’ Stock Analysis page.